Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.41% | -10.26% | -54.29% | 100.79% | 3.11% |
| Total Depreciation and Amortization | 63.49% | 114.29% | 599.43% | 169.01% | 75.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.65% | -30.38% | 3,153.81% | -239.62% | 96.92% |
| Change in Net Operating Assets | 96.50% | -14.29% | -116.84% | -97.36% | -19.96% |
| Cash from Operations | 50.26% | -16.90% | 3.19% | -238.37% | -1.87% |
| Capital Expenditure | 27.02% | -- | -273.78% | -- | 37.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,085.88% | 102.26% | 1,139.96% | 398.95% | 103.29% |
| Cash from Investing | -1,137.20% | 102.07% | 1,008.16% | 398.93% | 103.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,783.87% | -- | -- | -- | 6.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,753.35% | -- | -- | -- | 5.95% |
| Foreign Exchange rate Adjustments | -112.61% | 99.01% | 124.90% | -78.81% | 1,780.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.44% | 10,705.16% | 272.76% | 577.68% | 88.90% |